These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7204551)

  • 41. Evidence for three separate antigenic sites on the G1 protein of La Crosse Virus.
    Grady LJ; Sanders ML; Campbell WP
    Virology; 1983 Apr; 126(1):395-7. PubMed ID: 6189289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of proteolytic cleavage of La Crosse virus G1 glycoprotein on antibody neutralization.
    Kingsford L; Hill DW
    J Gen Virol; 1983 Oct; 64 (Pt 10)():2147-56. PubMed ID: 6352863
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Capture immunoglobulin M system for rapid diagnosis of La Crosse (California encephalitis) virus infections.
    Jamnback TL; Beaty BJ; Hildreth SW; Brown KL; Gundersen CB
    J Clin Microbiol; 1982 Sep; 16(3):577-80. PubMed ID: 6752195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. California serogroup virus infections in the Ryazan region of the USSR.
    Demikhov VG; Chaitsev VG; Butenko AM; Nedyalkova MS; Morozova TN
    Am J Trop Med Hyg; 1991 Sep; 45(3):371-6. PubMed ID: 1928573
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recently introduced Aedes albopictus in the United States: potential vector of La Crosse virus (Bunyaviridae: California serogroup).
    Grimstad PR; Kobayashi JF; Zhang MB; Craig GB
    J Am Mosq Control Assoc; 1989 Sep; 5(3):422-7. PubMed ID: 2584976
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity.
    Grady LJ; Kinch W
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2773-6. PubMed ID: 4067586
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Distribution of California serogroup viruses and virus infections in Canada.
    Artsob H
    Prog Clin Biol Res; 1983; 123():277-90. PubMed ID: 6135222
    [No Abstract]   [Full Text] [Related]  

  • 48. Effect of cyclophosphamide on the infection of mice with Tahyna virus.
    Hubálek Z; Bárdos V
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Dec; 251(2):145-51. PubMed ID: 7200298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. California serogroup and Powassan virus infection of cats.
    Keane DP; Parent J; Little PB
    Can J Microbiol; 1987 Aug; 33(8):693-7. PubMed ID: 2825952
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of neutralizing antibody to Jamestown Canyon virus (California group) in populations of elk and moose in northern Michigan and Ontario, Canada.
    Grimstad PR; Schmitt SM; Williams DG
    J Wildl Dis; 1986 Oct; 22(4):453-8. PubMed ID: 3503129
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biological activities of monoclonal antibodies reactive with antigenic sites mapped on the G1 glycoprotein of La Crosse virus.
    Kingsford L; Ishizawa LD; Hill DW
    Virology; 1983 Sep; 129(2):443-55. PubMed ID: 6194614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibodies to the California group of arboviruses in the moose (Alces alces americana Clinton) population of Nova Scotia.
    McFarlane BL; Embil JA; Artsob H; Spence L; Rozee KR
    Can J Microbiol; 1981 Nov; 27(11):1219-23. PubMed ID: 7317859
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human infections with La Crosse virus in Georgia, 1982.
    Sikes RK; Calisher CH; Smith JD
    South Med J; 1984 Aug; 77(8):972-4. PubMed ID: 6463696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A nonspecific inhibitor of hemagglutination by Tahyna virus in acetone-extracted mouse sera and its removal.
    Juricová Z; Hubálek Z; Príkazský Z
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Mar; 254(1):26-33. PubMed ID: 6675343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A serologic study of California serogroup bunyaviruses in Sri Lanka.
    Arunagiri CK; Perera LP; Abeykoon SB; Peiris JS
    Am J Trop Med Hyg; 1991 Sep; 45(3):377-82. PubMed ID: 1928574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Production of hemagglutinating of La Crosse virus by polyethylene glycol precipitation.
    Rabson M; Beaty BJ; Hildreth SW; Shope RE
    J Clin Microbiol; 1981 Mar; 13(3):601-2. PubMed ID: 7240391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Jamestown Canyon virus: the etiologic agent of an emerging human disease?
    Deibel R; Srihongse S; Grayson MA; Grimstad PR; Mahdy MS; Artsob H; Calisher CH
    Prog Clin Biol Res; 1983; 123():313-25. PubMed ID: 6191343
    [No Abstract]   [Full Text] [Related]  

  • 58. California arbovirus (La Crosse) infections. I. Clinical and laboratory findings in 66 children with meningoencephalitis.
    Balfour HH; Siem RA; Bauer H; Quie PG
    Pediatrics; 1973 Nov; 52(5):680-91. PubMed ID: 4355363
    [No Abstract]   [Full Text] [Related]  

  • 59. Experimental infection of chipmunks and snowshoe hares with La Crosse and snowshoe hare viruses and four of their reassortants.
    Seymour C; Amundson TE; Yuill TM; Bishop DH
    Am J Trop Med Hyg; 1983 Sep; 32(5):1147-53. PubMed ID: 6625069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of monoclonal antibodies against the G1 and N proteins of LaCrosse and Tahyna, two California serogroup bunyaviruses.
    Gonzalez-Scarano F; Shope RE; Calisher CE; Nathanson N
    Virology; 1982 Jul; 120(1):42-53. PubMed ID: 7101727
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.